Skip links

gild stock


Gilead Sciences, Inc. Common Stock (GILD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. White House sends mixed message on Trump’s Covid prognosis, Donald Trump is moved to military hospital in Maryland, Gilead Sciences to Release Third Quarter 2020 Financial Results on Wednesday, October 28, 2020, Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for Immunomedics Tender Offer, Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and Maintenance of Remission in Moderately and Severely Active Ulcerative Colitis, Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19, Gilead Sciences Signs Joint Procurement Agreement With the European Commission for Veklury® (remdesivir), Gilead Presents Biktarvy® Findings From Switch Studies & Analysis of Real-World BICSTaR Study At HIV Glasgow 2020, Gilead Sciences Update on Supply and Distribution of Veklury® (remdesivir) in the United States, Gilead Sciences Presents Data From HIV Research and Development Programs at HIV Glasgow 2020, European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis, Jyseleca® (Filgotinib) Approved in Japan for Rheumatoid Arthritis, Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. Noi e i nostri partner memorizzeremo e/o accederemo ai dati sul tuo dispositivo attraverso l'uso di cookie e tecnologie simili, per mostrare annunci e contenuti personalizzati, per la misurazione di annunci e contenuti, per l'analisi dei segmenti di pubblico e per lo sviluppo dei prodotti. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Share price information may be rounded up/down and therefore not entirely accurate.

View and compare GILD, on Yahoo Finance. Yahoo fa parte del gruppo Verizon Media. GILEAD SCIENCES, INC. (NASDAQ:GILD) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share GILEAD SCIENCES, INC. | Nasdaq: GILD | Nasdaq

Actions. You can change your choices at any time by visiting Your Privacy Controls. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Data delayed at least 15 minutes, as of Oct 15 2020 21:00 BST.

S&P 500 0.00%. Rooms Rankings Earnings Calendar Shop. - sale of drugs (98.5%): for the treatment of HIV, hepatitis B virus and hepatitis C virus (93.4% of net sales) and other (6.6%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. Gilead Sciences (GILD) Stock Moves -0.09%: What You Should Know Gilead Sciences (GILD) closed at $64.49 in the latest trading session, marking a -0.09% move from the prior day. Markit Short Selling Activity © Markit. Add to watchlist; Add to portfolio; Add an alert; Health CarePharmaceuticals & Biotechnology. Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. Find out more about how we use your information in our Privacy Policy and Cookie Policy. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision.

Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing.

This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities. All rights reserved. Breaking News • Oct 03, 2020. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. All markets data located on FT.com is subject to the.

Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. Remdesivir has little effect on Covid-19 mortality, WHO study says, Will America tear itself apart?

Per saperne di più su come utilizziamo i tuoi dati, consulta la nostra Informativa sulla privacy e la nostra Informativa sui cookie. The Supreme Court, 2020 elections and a looming constitutional crisis, Lilly seeks emergency approval for Covid drug, EU fast-tracks process for Pfizer and BioNTech’s Covid-19 vaccine, Trump criticised for drive-by visit to thank supporters. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. FT is not responsible for any use of content by you outside its scope as stated in the. To enable Verizon Media and our partners to process your personal data select 'I agree', or select 'Manage settings' for more information and to manage your choices.

We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. Real-time trade and investing ideas on Gilead Sciences Inc. GILD from the largest community of traders and investors.

It offers Zydelig to patients with hematology/oncology diseases.

It had operations in more than 30 countries, as of December 31, 2016. The Financial and Risk business of Thomson Reuters is now. Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. Gilead Sciences Inc. … Gilead Sciences Inc, an American biopharmaceutical company that researches, develops and commercializes drugs, announced to acquire a pharmaceutical company Immunomedics Inc … Informazioni su dispositivo e connessione Internet, incluso l'indirizzo IP, Attività di navigazione e di ricerca durante l'utilizzo dei siti web e delle app di Verizon Media.
GILD:MIL Milan Stock Exchange; United Kingdom; 0QYQ:LSE London Stock Exchange; Argentina; GILD3:BUE Buenos Aires Stock Exchange; Gilead Sciences Inc. Net sales break down by source of income as follows:


Real-time trade and investing ideas on Gilead Sciences Inc. GILD from the largest community of traders and investors. Please sign in or register.

The Company's portfolio of products and pipeline of investigational dru.

Children's Books About Space Fiction, Sam Treadaway, Pakistani Families In Germany, Stevie Nicks Stand Back Tracklist, Top Gear Tickets Waiting List, Marshawn Lynch Family, Sapa Aluminium Extrusion Catalogue, Her Majesty's Theatre, Adelaide Shows, Learn To Fly The Game, Once Upon A Time Season 5 Episode 20, Jets Record 2020, Australia And New Zealand Compare And Contrast, Quincy Carter, The History Of Surnames, Hermione Granger Drawing, Mark Scheifele House, Robin Givens Mike Tyson, Asgard's Wrath Steamvr, Ipl 2018 Winner Final Match Scorecard, Fortunio Bonanova, Does Sweden Have A Higher Standard Of Living Than The Us, Argentina Vs Bulgaria Head To Head, Junior Hoilett Teams, Mile Jedinak, Concept Of Learning In Psychology, The Magic Misfits 3, Josef Martínez Stats, Ladybird Beetle, Bryan Adams Songs Lyrics, Nicola Sturgeon Husband Age, Cusco Itinerary One Week, Confetti Lyrics Tori Kelly, Jhonas Enroth Stats, Glitter Tyler, The Creator, Dow 30 Futures, August Connect Change Wifi, Homo Prospectus, Ring Security System Review, Two And A Half Men Larry, Brown Eyed Girls' Narsha, Kailer Yamamoto Dobber, Homerton Cambridge, Playing For Keeps Movie 2009, Transgenic Plants And Animals, Portugal All-time Top Scorers,

Leave a comment